Clinical Trials for Greenwich LifeSciences

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Greenwich LifeSciences

Clinical Trials (1)

NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3Recruiting
750 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor161 locations